Jane Street’s Axonics, Inc. Common Stock AXNX Stock Holding History

Jane Street’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,200	Closed	-$1.43M	–	10622
2024 Q2	$1.43M	Sell	21,200 -1,700	-7%	-$115K	﹤0.01%	5104
2024 Q1	$1.58M	Buy	22,900 +18,800	+459%	+$1.27M	﹤0.01%	4557
2023 Q4	$255K	Buy	+4,100	New	+$229K	﹤0.01%	7866
2022 Q2	–	Sell	-31,400	Closed	-$1.97M	–	11163
2022 Q1	$1.97M	Buy	31,400 +4,400	+16%	+$237K	﹤0.01%	4792
2021 Q4	$1.51M	Buy	27,000 +22,700	+528%	+$1.39M	﹤0.01%	5061
2021 Q3	$280K	Sell	4,300 -9,000	-68%	-$614K	﹤0.01%	8329
2021 Q2	$843K	Sell	13,300 -3,000	-18%	-$177K	﹤0.01%	6205
2021 Q1	$976K	Buy	16,300 +9,600	+143%	+$522K	﹤0.01%	5503
2020 Q4	$334K	Sell	6,700 -21,300	-76%	-$1M	﹤0.01%	6264
2020 Q3	$1.43M	Buy	+28,000	New	+$1.17M	﹤0.01%	3534

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's AXNX Position: Q4 2024 in Review

Jane Street sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 30,545 shares — an estimated $2.13M sold.

Jane Street first reported a position in AXNX in Q1 2020 and held it in 19 quarters. The position peaked at $3.82M in Q2 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Jane Street reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Jane Street sold 30,545 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.13M.
Jane Street first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 19 quarters.
Jane Street's Axonics, Inc. Common Stock position peaked at $3.82M in Q2 2022.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.